Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Plasma Cell Disorders Multiple Myeloma Relapsed/Refractory 3 or more prior lines
Categories
Protocols
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
A Phase 1, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 2001 in Subjects with Relapsed/Refractory Multiple Myeloma